Ligand validation:3ZQ9

EDO: 1,2-ETHANEDIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3ZQ9_EDO_A_1527	90%	63%	0.093	0.976	0.59	0.81	-	-	0	0	100%	1
3ZQ9_EDO_A_1525	88%	66%	0.092	0.967	0.55	0.74	-	-	0	0	100%	1
3ZQ9_EDO_A_1526	70%	84%	0.132	0.951	0.39	0.38	-	-	0	0	100%	1
3ZQ9_EDO_A_1528	56%	87%	0.172	0.944	0.46	0.24	-	-	0	0	100%	0.5
2YIH_EDO_A_1525	98%	70%	0.065	0.984	0.41	0.74	-	-	0	0	100%	1
2YJQ_EDO_B_1529	92%	88%	0.097	0.988	0.61	0.08	-	-	3	0	100%	0.5
2G8S_EDO_A_3016	100%	84%	0.02	0.992	0.42	0.35	-	-	0	0	100%	0.5
3DPJ_EDO_B_195	100%	82%	0.022	0.994	0.47	0.34	-	-	1	0	100%	1
4EYG_EDO_A_402	100%	81%	0.024	0.995	0.44	0.39	-	-	0	0	100%	1
4NMU_EDO_D_206	100%	92%	0.025	0.997	0.38	0.14	-	-	0	0	100%	1
4Q6J_EDO_A_302	100%	82%	0.013	0.999	0.37	0.42	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.